Commentary on ‘Resveratrol commonly displays hormesis: Occurrence and biomedical significance’ by Calabrese et al

De la Lastra CA , Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res 2005; 49: 405-430.

De la Lastra, Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 2007; 35: 1156-1160.

Calabrese EJ Cancer biology and hormesis: human tumor cell lines commonly display hormetic (biphasic) dose responses. Crit Rev Toxicol 2005; 35: 463-582.

Dudley J. , Das S. , Mukherjee S. , and Das DK Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J Nutr Biochem 2009; 20: 443-452.

Dey A. , Guha P. , Chattopadhyay S. , and Bandyopadhyay SK Biphasic activity of resveratrol on indomethacininduced gastric ulcers. Biochem Biophys Res Comm 2009 ; 381: 90-95.

Solmaz A. , Sener G. , Cetinel S. , Yüksel M. , Yeğen C. , and Yeğen BC Protective and therapeutic effects of resveratrol on acetic acid-induced gastric ulcer. Free Radic Res 2009; 43: 594-603.

Martin AR , Villegas I. , La Casa C. , de la Lastra CA Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem Pharmacol 2004; 67: 1399-1410.

Martin AR , Villegas I. , Sánchez-Hidalgo M. , and de la Lastra CA The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br J Pharmacol 2006; 147: 873-885.

Sanchez-Fidalgo S. , Cárdeno A. , Villegas I. , Talero E. , and de la Lastra CA Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur J Pharmacol 2010; 633: 78-84.

Cottart CH , Nivet-Antoine V. , Laguillier-Morizot C. , and Beaudeux JL Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res 2010; 54: 7-16.

Crowell JA , Korytko PJ , Morrissey RL , Booth TD , and Levine BS Resveratrol-associated renal toxicity. Toxicol Sci 2004; 82: 614-619.

Juan ME , Vinardell MP , and Planas JM The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr 2002; 132: 257-260.

Williams LD , Burdock GA , Edwards JA , Beck M. , and Bausch J. Safety studies conducted on high-purity transresveratrol in experimental animals. Food Chem. Toxicol 2009; 47: 2170-2182.

Boocock DJ , Faust GE , Patel KR , Schinas AM , et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 2007; 16: 1246-1252.

Almeida L. , Vaz-da-Silva M. , Falcao A. , Soares E. , et al. Pharmacokinetic and safety profile of transresveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res 2009; 53: S7-S15.

Vaz-da-Silva M. , Loureiro AI , Falcao A. , Nunes T. , et al. Effect of food on the pharmacokinetic profile of transresveratrol. Int J Clin Pharmacol Ther 2008; 46: 564-570.